✦ LIBER ✦

Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma

✍ Scribed by Mastro, A. A.; Beneduce, G.; Castello, G.; De Rosa, V.; Petrillo, A.; Glazer, E. S.; Piccirillo, M.; Albino, V.; Di Giacomo, R.; Palaia, R.

Book ID: 115482250
Publisher: American Society of Clinical Oncology
Year: 2010
Tongue: English
Weight: 274 KB
Volume: 28
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2009.26.7765

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised phase II study of pegylated

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

✍ Yang, T-S; Lu, S-N; Chao, Y; Sheen, I-S; Lin, C-C; Wang, T-E; Chen, S-C; Wang, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 431 KB

Phase I/II study of pegylated arginine d

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

✍ Ott, Patrick A.; Carvajal, Richard D.; Pandit-Taskar, Neeta; Jungbluth, Achim A. 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 490 KB

Phase II studies with DaunoXome in patie

Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes

✍ Winnie Yeo; Kenneth K. Chan; Geoffrey Mukwaya; Michael Ross; W. T. Leung; Stephe 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 116 KB

Phase II study of doxorubicin and cispla

Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma

✍ Jeeyun Lee; Joon Oh Park; Won Seog Kim; Se Hoon Park; Keon Woo Park; Moon Seok C 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 205 KB

Down-regulation of argininosuccinate syn

Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy

✍ Jennifer A McAlpine,Hsin-Tze Lu,Katherine C Wu,Susan K Knowles… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 893 KB

A phase II and pharmacokinetic study of

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB